Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004550 · ClinicalTrials.gov registry record
Evaluation and Follow-up of Individuals With Obsessive-Compulsive Disorder and Related Conditions
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 400
- Enrollment target
NCT00004550: Completed study, sponsored by National Institute of Mental Health (NIMH).
NCT00004550 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004550 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand the long-term progress of people with obsessive-compulsive disorder (OCD) and related conditions such as anorexia nervosa, Tourette syndrome, and trichotillomania. This study involves the screening and follow-up of individuals with OCD and OCD-related disorders. Participants will be screened with a medical and psychiatric evaluation, questionnaires, and neurological testing. Participants will then have study visits every 4 to 12 weeks to undergo symptom and daily functioning evaluations, personality tests, blood and urine tests, memory tests, brain scans, and other clinical exams. Participants will be assessed with interviews and paper-and-pencil or computer-assisted tests. Participants may have the opportunity to participate in drug studies and to join a monthly OCD support group. At the end of the study, participants will be referred to community or private treatment centers.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2000-01-28 |
| Est. Completion | 2008-04-21 |
What the finished NCT00004550 record still lists
NCT00004550 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00004550 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004550 about?
NCT00004550 is a clinical study titled "Evaluation and Follow-up of Individuals With Obsessive-Compulsive Disorder and Related Conditions". The purpose of this study is to better understand the long-term progress of people with obsessive-compulsive disorder (OCD) and related conditions such as anorexia nervosa, Tourette syndrome, and trichotillomania. This study involves the screening and follow-up of individuals with OCD and OCD-relat...
What is the current status of trial NCT00004550?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2000-01-28. Estimated completion is 2008-04-21.
Who is sponsoring clinical trial NCT00004550?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI